John Polo
27Patents
18h-index
23Co-inventors
81Inventor score
Filing activity: Mar 15, 1995 → Aug 20, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5814482A | Eukaryotic layered vector initiation systems | Emerging Cross-Sectional Technologies | 202 | Expired |
| US5843723A | Alphavirus vector constructs | Emerging Cross-Sectional Technologies | 162 | Expired |
| US5789245A | Alphavirus structural protein expression cassettes | Emerging Cross-Sectional Technologies | 150 | Expired |
| US6015686A | Eukaryotic layered vector initiation systems | Emerging Cross-Sectional Technologies | 127 | Expired |
| US6015694A | Method for stimulating an immune response utilizing recombinant alphavirus particles | Emerging Cross-Sectional Technologies | 97 | Expired |
| US6376236B1 | Recombinant alphavirus particles | Emerging Cross-Sectional Technologies | 61 | Expired |
| US6329201A | Compositions and methods for packaging of alphavirus vectors | Chemistry; Metallurgy | 41 | Expired |
| US6342372B1 | Eukaryotic layered vector initiation systems for production of recombinant proteins | Emerging Cross-Sectional Technologies | 41 | Expired |
| US7811812B2 | Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis | Chemistry; Metallurgy | 38 | Expired |
| US6242259A | Compositions and methods for packing of alphavirus vectors | Chemistry; Metallurgy | 37 | Expired |
| US7977091B2 | Eukaryotic layered vector initiation systems | Emerging Cross-Sectional Technologies | 36 | Active |
| US6767699B2 | Method for the quantitation of alphavirus replicon particles | Chemistry; Metallurgy | 34 | Expired |
| US7771979B2 | Compositions and methods for generating an immune response utilizing alphavirus-based vector systems | Chemistry; Metallurgy | 32 | Active |
| US6391632B1 | Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis | Chemistry; Metallurgy | 28 | Expired |
| US6426196B1 | Alphavirus structural protein expression cassettes | Chemistry; Metallurgy | 26 | Expired |
| US6451592B1 | Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis | Chemistry; Metallurgy | 19 | Expired |
| US8647864B2 | Compositions and methods for generating an immune response utilizing alphavirus-based vector systems | Chemistry; Metallurgy | 19 | Active |
| US9255126B2 | Chimeric alphavirus replicon particles | Chemistry; Metallurgy | 18 | Active |
| US7572453B2 | Chimeric alphavirus replicon particles | Chemistry; Metallurgy | 17 | Active |
| US7744900B2 | Enhancement of the immune response for vaccine and gene therapy applications | Human Necessities | 15 | Active |
| US7531180B2 | Chimeric alphavirus replicon particles | Chemistry; Metallurgy | 15 | Expired |
| US8158418B2 | Chimeric alphavirus replicon particles | Chemistry; Metallurgy | 14 | Active |
| US6465634B1 | Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis | Chemistry; Metallurgy | 12 | Expired |
| US7572628B2 | Eukaryotic layered vector initiation systems | Emerging Cross-Sectional Technologies | 10 | Expired |
| US9024001B2 | Alphavirus replicon packaging constructs | Chemistry; Metallurgy | 9 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.